Limited gene expression variation in human embryonic stem cell and induced pluripotent stem cell-derived endothelial cells

Stem Cells

Volumn 31, Issue 1, 2013, Pages 92-103

  White, Mark P ^a,b   Rufaihah, Abdul J ^c,d   Liu, Lei ^a,b   Ghebremariam, Yohannes T ^c   Ivey, Kathryn N ^a,b   Cooke, John P ^c   Srivastava, Deepak ^a,b  

^a GLADSTONE INSTITUTE OF CARDIOVASCULAR DISEASE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Cell differentiation; Endothelial cell; Induced pluripotent stem cells; Stem cells

Indexed keywords

CD31 ANTIGEN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GROWTH FACTOR; TRANSCRIPTOME; VASCULAR ENDOTHELIAL CADHERIN; VON WILLEBRAND FACTOR;

ARTICLE; CELL DIFFERENTIATION; CELL LINE; CELL LINEAGE; CELL SUBPOPULATION; CONTROLLED STUDY; EMBRYO DEVELOPMENT; EMBRYOID BODY; EMBRYONIC STEM CELL; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIUM CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; MESODERM; NUCLEOTIDE SEQUENCE; PLURIPOTENT STEM CELL; PROTEIN EXPRESSION; PURIFICATION; STEM CELL EXPANSION;

CELL DIFFERENTIATION; CELL LINE; CELL LINEAGE; EMBRYONIC STEM CELLS; ENDOTHELIAL CELLS; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENETIC VARIATION; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MESODERM; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR ALPHA; TRANSCRIPTOME; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

IPS;

EID: 84871558573     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.1267     Document Type: Article

References (33)

1. Robinton DA, Daley GQ. The promise of induced pluripotent stem cells in research and therapy. Nature 2012;481:295-305.
2. Leeper NJ, Hunter AL, Cooke JP. Stem cell therapy for vascular regeneration: Adult, embryonic, and induced pluripotent stem cells. Circulation 2010;122:517-526.
3. Cooke JP. Flow, NO, and atherogenesis. Proc Natl Acad Sci USA 2003;100:768-770. (Pubitemid 36183903)
4. Cho SW, Moon SH, Lee SH et al. Improvement of postnatal neovascularization by human embryonic stem cell-derived endothelial-like cell transplantation in a mouse model of hindlimb ischemia. Circulation 2007;116:2409-2419.
5. Wang ZZ, Au P, Chen T et al. Endothelial cells derived from human embryonic stem cells form durable blood vessels in vivo. Nat Biotechnol 2007;25:317-318. (Pubitemid 46398769)
6. Rufaihah AJ, Huang NF, Jame S et al. Endothelial cells derived from human iPSCs increase capillary density and improve perfusion in a mouse model of peripheral arterial disease. Arterioscler Thromb Vasc Biol 2011;31:e72-e79.
7. Descamps B, Emanueli C. Vascular differentiation from embryonic stem cells: Novel technologies and therapeutic promises. Vascul Pharmacol 2012;56:267-279.
8. Nourse MB, Halpin DE, Scatena M et al. VEGF induces differentiation of functional endothelium from human embryonic stem cells: Implications for tissue engineering. Arterioscler Thromb Vasc Biol 2010;30:80-89.
9. Kane NM, Xiao Q, Baker AH et al. Pluripotent stem cell differentiation into vascular cells: A novel technology with promises for vascular re(generation). Pharmacol Ther 2011;129:29-49.
10. Kane NM, Meloni M, Spencer HL et al. Derivation of endothelial cells from human embryonic stem cells by directed differentiation: Analysis of microRNA and angiogenesis in vitro and in vivo. Arterioscler Thromb Vasc Biol 2010;30:1389-1397.
11. James D, Nam H-S, Seandel M et al. Expansion and maintenance of human embryonic stem cell-derived endothelial cells by TGFbeta inhibition is Id1 dependent. Nat Biotechnol 2010;28:161-166.
12. Kattman SJ, Witty AD, Gagliardi M et al. Stage-specific optimization of activin/nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines. Cell Stem Cell 2011;8:228-240.
13. Li Z, Hu S, Ghosh Z et al. Functional characterization and expression profiling of human induced pluripotent stem cell- and embryonic stem cell-derived endothelial cells. Stem Cells Dev 2011;20:1701-1710.
14. Tatsumi R, Suzuki Y, Sumi T et al. Simple and highly efficient method for production of endothelial cells from human embryonic stem cells. Cell Transplant 2011;20:1423-1430.
15. Nakamura K, Salomonis N, Tomoda K et al. G(i)-coupled GPCR signaling controls the formation and organization of human pluripotent colonies. PLoS One 2009;4:7780.
16. Byrne JA, Nguyen HN, Reijo Pera RA. Enhanced generation of induced pluripotent stem cells from a subpopulation of human fibroblasts. PLoS One 2009;4:7118.
17. Smyth, GK. Limma: linear models for microarray data. In: Bioinformatics and Computational Biology Solutions using R and Bioconductor. Gentleman R, Carey V, Dudoit S, Irizarry R, Huber W (editors), Springer, 2005;397-420.
18. Kattman SJ, Huber TL, Keller GM. Multipotent flk-1+ cardiovascular progenitor cells give rise to the cardiomyocyte, endothelial, and vascular smooth muscle lineages. Dev Cell 2006;11:723-732. (Pubitemid 44644969)
19. Yang L, Soonpaa MH, Adler ED et al. Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population. Nature 2008;453:524-528. (Pubitemid 351733312)
20. Yamashita J, Itoh H, Hirashima M et al. Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors. Nature 2000;408:92-96.
21. Olsson A-K, Dimberg A, Kreuger J et al. VEGF receptor signalling - In control of vascular function. Nat Rev Mol Cell Biol 2006;7:359-371.
22. Cross MJ, Claesson-Welsh L. FGF and VEGF function in angiogenesis: Signalling pathways, biological responses and therapeutic inhibition. Trends Pharmacol Sci 2001;22:201-207. (Pubitemid 32244307)
23. Grant DS, Kleinman HK, Martin GR. The role of basement membranes in vascular development. Ann N Y Acad Sci 1990;588:61-72. (Pubitemid 20203368)
24. Gupta MK, Illich DJ, Gaarz A et al. Global transcriptional profiles of beating clusters derived from human induced pluripotent stem cells and embryonic stem cells are highly similar. BMC Dev Biol 2010;10:98.
25. Chin MH, Mason MJ, Xie W et al. Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Cell Stem Cell 2009;5:111-123.
26. Marchetto MCN, Yeo GW, Kainohana O et al. Transcriptional signature and memory retention of human-induced pluripotent stem cells. PLoS One 2009;4:e7076.
27. Ho M, Yang E, Matcuk G et al. Identification of endothelial cell genes by combined database mining and microarray analysis. Physiol Genomics 2003;13:249-262. (Pubitemid 37129190)
28. Yamamizu K, Matsunaga T, Uosaki H et al. Convergence of Notch and -catenin signaling induces arterial fate in vascular progenitors. J Cell Biol 2010;189:325-338.
29. Lanner F, Sohl M, Farnebo F. Functional arterial and venous fate is determined by graded VEGF signaling and notch status during embryonic stem cell differentiation. Arterioscler Thromb Vasc Biol 2007;27:487-493.
30. Oliver G, Srinivasan RS. Endothelial cell plasticity: How to become and remain a lymphatic endothelial cell. Development 2010;137:363-372.
31. Marino D, Dabouras V, Brändli AW et al. A role for all-trans-retinoic acid in the early steps of lymphatic vasculature development. J Vasc Res 2011;48:236-251.
32. Sun C, Liu X, Qi L et al. Modulation of vascular endothelial cell senescence by integrin β4. J Cell Physiol 2010;225:673-681.
33. Bock C, Kiskinis E, Verstappen G et al. Reference maps of human ES and iPS cell variation enable high-throughput characterization of pluripotent cell lines. Cell 2011;144:439-452.